Background: Healthcare professionals must continuously update their competencies to keep pace with evolving clinical practices; however, traditional continuing professional development (CPD) methods often have limited impact on competency and performance. Micro-credentials have emerged as a flexible and personalized alternative to traditional CPD, yet little is known about how they are designed, implemented, and evaluated in health professions education. As educational systems invest heavily in micro-credentials, a clearer understanding of their educational value is essential. Methods: Using a scoping review guided by Arksey and O’Malley’s six-stage framework and PRISMA-ScR guidelines, we systematically searched seven databases (inception–December 2024) and conducted a structured grey literature review. We examined the instructional design features, pedagogical underpinnings, assessment strategies, and reported impacts of micro-credentials. Results: We included 19 peer-reviewed papers and 35 websites describing health-related micro-credentials. Most studies were published in 2024 (42.1%), originated from the United States (42.1%), and nearly half (47.4%) provided only descriptive accounts. A wide range of instructional design features were identified, though pedagogical theories were rarely stated. Assessment strategies predominantly emphasized summative approaches (e.g., multiple-choice knowledge checks), with limited focus on higher-level competency assessment. Reported outcomes were primarily improvements in knowledge, confidence, or engagement, with no clear evidence of the distinct value of micro-credentials as a teaching modality. Discussion: Current literature offers limited evaluation of micro-credentials and often lacks theory-informed design. We infer a pedagogical foundation aligned with constructivist, context-sensitive, and stage-based principles, which may inform the development of future micro-credential programs.
Background/Objectives: Aerosolized medications are common practice for mechanically ventilated pediatric patients. Infants often receive nebulized medications via hand ventilation using an anesthesia bag, but evidence on optimal aerosol delivery with this method is limited. For this study, various configurations of the Mapleson breathing circuit were tested to optimize albuterol delivery to a simulated pediatric model. Methods: Using a simulated pediatric lung model (ASL 5000) with the semi-open Mapleson anesthesia circuit, 2.5 mg/3 mL of albuterol sulfate solution was nebulized to a viral/bacterial filter (Respiguard 202). Four models were compared with varying fresh gas flows (FGFs), small-volume nebulizer (SVN) placements, and adjusting dead space. Five Registered Respiratory Therapists (RRTs) bagged the aerosol into a collection filter following defined ventilation parameters. Each model was tested in random order to avoid fatigue bias. Albuterol concentrations eluted from in-line filters were measured by spectrophotometry (absorbance at 276 nm). Results: No inter-user variability was observed among the RRTs. Significant differences in albuterol recovered were noted between models (One Way ANOVA, Tukey’s post hoc, n = 5). Model 4, with the nebulizer closest to the collecting filter, recovered 21.77 ± 1.89% of albuterol. The standard clinical model was the least effective, with only 0.10 ± 0.17% albuterol recovery. Conclusions: Modifying the anesthesia breathing circuit significantly improved aerosol drug delivery efficiency. Our findings suggest that current clinical practices for nebulized drug delivery are inefficient and can be markedly improved with simple adjustments in nebulizer positioning and gas flow within the circuit.
Aerosolized medications are often required in mechanically ventilated infants to resolve complex respiratory issues. Current practice utilizes hand ventilation, via an anesthesia bag, to deliver nebulized medications. However, there is little evidence to ensure optimal delivery of medications. Using a simulated pediatric lung model (ASL 5000), with a Mapleson anesthesia breathing circuit, we delivered 2.5 mg albuterol sulfate to a viral/bacterial filter (Respiguard 202). We compared four configurations with varied fresh gas flows (FGF) and nebulizer placements. Five Registered Respiratory Therapists (RRT) delivered the aerosol into the collection filter targeting the defined ventilation parameters. Each configuration was tested in random order by each RRT to avoid fatigue bias. After albuterol delivery, eluded albuterol sulfate concentration was determined by spectrophotometry. We measured no inter-user variability. We measured significant differences in the efficacy of albuterol delivery between each configuration (One Way ANOVA, Tukey’s post hoc, N=5). The configuration with the nebulizer closest to the airway was most effective, as we recovered 22.6±1.8% of albuterol. The standard clinical model was least effective, as only 0.6±0.9% of albuterol was recovered. Configurations 2 and 3, in which the FGF was reduced, and the nebulizer was moved proximal to the FGF also increased albuterol, with 4.2±1.5% and 14.0±1.7% recovery, respectively. Significant efficiency of nebulized drug delivery using an anesthesia breathing circuit can be achieved using alternate configurations. Our data suggests that current clinical approaches are inefficient but could be markedly improved with relatively simple changes.